C3 glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review

Basaran O., Uncu N., Cakar N., Turanli E. T., Kiremitci S., Aydin F., ...More

RHEUMATOLOGY INTERNATIONAL, vol.38, no.8, pp.1571-1576, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 38 Issue: 8
  • Publication Date: 2018
  • Doi Number: 10.1007/s00296-018-4092-3
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1571-1576
  • Keywords: Autoinflammatory disease, C3 glomerulopathy, NLRP12, Pediatric, NLRP3
  • Hacettepe University Affiliated: Yes


Autoinflammatory diseases (AIDs) are a recently described group of conditions caused by mutations in multiple genes that code for proteins of the innate immune system. Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory diseases comprising three clinically overlapping disorders: familial cold urticarial syndrome (FCAS), Muckle-Wells syndrome (MWS), and neonatal-onset multisystem inflammatory disease (NOMID). CAPS have been associated with gain-of-function variations in NLRP3 (NOD-like receptor family, pyrin containing domain-3). However, a new class of autoinflammatory disease resembling FCAS or MWS has been described in patients with NLRP12 mutations. Here, we report a 6-year-old boy diagnosed with AID who developed an unexpected C3 glomerulopathy during attacks and carried a novel variation in NLRP12. Following treatment with IL (interleukin) 1 targeting agents, all symptoms and inflammation resolved. This is the first case in the literature affected by both autoinflammatory disease and C3 glomerulopathy.